Skip to main content

Psych Congress Year-Round

Psych Congress Year-Round
BLOG: Have you ever wished you could pick up the phone and call someone you’ve lost and leave them a message?
PSYCH CONGRESS NEWSROOM
SAN DIEGO—Cannabidiol (CBD) has quickly entered the mainstream, but there is a dearth of evidence about the effects of the cannabis byproduct, a speaker told a large audience at Psych Congress 2019.
PSYCH CONGRESS NEWSROOM
SAN DIEGO—Mindfulness meditation is an effective, evidence-based treatment which can improve symptoms of anxiety, depression, and other mental health conditions, two speakers told attendees at a Psych Congress 2019 session.
PSYCH CONGRESS NEWSROOM
SAN DIEGO—Charles F. Zorumski, MD, presented an update on gamma-aminobutyric acid (GABA), a complex neurotransmitter he has been studying for more 30 years, at the Psych Congress 2019 Practical Psychopharmacology Pre-Conference.
Psych Congress Year-Round
View or download the full official 2019 Psych Congress preview here.
PSYCH CONGRESS NEWSROOM
Get a behind-the-scenes look at some of the sessions taking place at the 32nd annual Psych Congress, and meet the experts presenting them.
Psych Congress Year-Round
In concurrence with National Suicide Prevention Month, HMP, a leading healthcare education and events company, announced the launch of the Suicide Prevention 360 initiative.
Psych Congress Year-Round
Psych Congress has announced three new mental health experts will join its Steering Committee.
General Psychiatry
Arshya Vahabzadeh, MD, understands the power neurotechnology can have in the lives of patients. The technology expert recently shared some thoughts on the future of psychiatry, which he will expand upon during his featured session at Psych Congress.
Psych Congress Year-Round
Psych Congress is pleased to announce on World Suicide Prevention Day that our 2019 charitable partner for the upcoming Congress in San Diego is the American Foundation for Suicide Prevention (AFSP).
General Psychiatry
Andrew Penn, RN, MS, NP, CNS, APRN-BC
BLOG: Currently, many of our patients are using cannabinoids, especially cannabidiol (CBD) to treat their own symptoms—ranging from insomnia, to anxiety, to depression.
Back to Top